# COVID-19 Seroprevalence Study in French Guiana

> **NCT04490850** · NA · COMPLETED · sponsor: **Institut Pasteur** · enrollment: 3541 (actual)

## Conditions studied

- Coronavirus Infection
- Severe Acute Respiratory Syndrome
- SARS-CoV Infection
- Covid19

## Interventions

- **PROCEDURE:** Blood sample

## Key facts

- **NCT ID:** NCT04490850
- **Lead sponsor:** Institut Pasteur
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-15
- **Primary completion:** 2021-09-24
- **Final completion:** 2021-09-24
- **Target enrollment:** 3541 (ACTUAL)
- **Last updated:** 2022-02-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04490850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04490850, "COVID-19 Seroprevalence Study in French Guiana". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04490850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*